Archive

Tag: ESETT Trial

The ESETT Trial: 2nd Line Medications in Status Epilepticus

Background: Dealing with a patient in status epilepticus, refractory to treatment with benzodiazepines, can be a sphincter tightening ordeal.  While most seizure activity responds to appropriately dosed benzodiazipines, some will not respond. The choice of second line medication has been …

Read More
Neurology

Sponsored

0